AGP Picks
View all

IV.ai Solutions founder pushes responsible AI in healthcare

Jul. 24, 2026
By AI, Created 11:16 UTC, Jul 24, 2026, AGP -

Ines Voellinger, founder and CEO of IV.ai Solutions, is building AI tools and training aimed at helping clinicians adopt technology without losing the human side of care. Her work centers on rural access, provider burnout and closing the AI literacy gap in healthcare.

Why it matters: - Health systems are under pressure from administrative burden, uneven access and growing demand for digital tools. - Voellinger is positioning AI as a way to support clinicians, not replace them. - Her focus on rural and underserved communities targets places where the gap between healthcare need and access is widest.

What happened: - Ines Voellinger, founder and CEO of IV.ai Solutions, is advancing healthcare AI work from Chattanooga, Tennessee. - IV.ai Solutions was established in late 2024. - Voellinger’s work centers on helping physicians, therapists and mental health providers evaluate and implement AI tools. - Her approach emphasizes practical use cases, clinical workflows and patient care outcomes.

The details: - Voellinger spent nearly 17 years in the global automotive sector before moving deeper into healthcare AI. - Her automotive career included building a product compliance program and a purchasing training academy. - She later led AI strategy and digital transformation work across North America, including enterprise AI deployments. - Voellinger says her background in safety-critical, highly regulated environments shaped her standards for integrity and accountability. - She is a CME faculty member with the Missouri Association of Osteopathic Physicians and Surgeons, the Tennessee Osteopathic Medical Association and VOCCME. - Her educational programs meet AOA and ACCME standards. - Voellinger has supported workshops for Reuters Digital Health. - In April 2026, she attended DMEA in Berlin and began building partnerships between European health tech innovators and U.S. healthcare providers. - IV.ai Solutions operates in both the United States and Germany. - Voellinger completed Stanford University’s AI in Healthcare program and the Digital Transformation in Healthcare course. - She also studied integrative and preventive health and was selected for the Harvard Emerging Leader Program. - Voellinger is a founding member of the AI TechX Consortium of Tennessee at the University of Tennessee, Knoxville. - The consortium brings together academia, government, industry, startups and healthcare leaders to position Tennessee as a national leader in applied AI. - Voellinger is developing The Trust Lab, a mobile initiative that would bring AI tools and wearable technology into rural communities through workshops and demonstrations. - The initiative is designed to help people ask questions, explore the technology and understand how it could support their health. - More information is available through Voellinger’s Influential Women profile. - More information is also available on IV.ai Solutions’ website.

Between the lines: - Voellinger’s message is that adoption depends on trust and comprehension, not just technical capability. - Her emphasis on AI literacy suggests the next barrier in healthcare is not tool availability but user confidence. - Her focus on burnout reflects a broader argument in health tech: automation has to free clinicians for patient care, not add another layer of work. - Her background in Germany and the U.S. gives IV.ai Solutions an unusually cross-border lens for healthcare innovation.

What's next: - Voellinger is likely to keep building partnerships that connect healthcare providers with responsible AI tools. - The Trust Lab concept points to future outreach in rural markets and community education. - Her CME and keynote work suggests continued efforts to prepare clinicians for new digital health tools before they become mainstream.

The bottom line: - Voellinger is betting that AI will matter most in healthcare when it is understandable, trustworthy and built around clinicians and patients rather than around hype.

Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.

Sign up for:

German Health Review

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

German Health Review

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.